Kenneth A. Newlander
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Cell Adhesion Molecules Research, Monoclonal and Polyclonal Antibodies Research, Antimicrobial Peptides and Activities, Antimicrobial agents and applications
Most-Cited Works
- → Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2(2012)375 cited
- → Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents(2002)163 cited
- → Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK(2003)161 cited
- → Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic(1999)116 cited
- → Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI)(2002)109 cited
- → Defining and Combating the Mechanisms of Triclosan Resistance in Clinical Isolates ofStaphylococcus aureus(2002)96 cited
- → Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists(1996)72 cited
- → Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents(2001)62 cited
- → Conformational Preferences in a Benzodiazepine Series of Potent Nonpeptide Fibrinogen Receptor Antagonists(1999)53 cited
- → Simple Silyl Linker for the Solid Phase Organic Synthesis of Aryl- Containing Molecules(1997)50 cited